Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S0.26
P/E—
Fwd P/E8.38
PEG0.76
52W— – —
RSI—
Target$339.36 (+20.9%)
Beta0.32
Div2.19%
Loading chart…
RSI ()
Loading patterns…
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 50
Overbought · 100
Signal
Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
6Bullish
5Bearish
0Neutral
Key Signals 2
▲ Double Bottom
Major reversal
2026-07-13 · $299.27
Two lows ~$271.26 — bullish reversal confirmed
Learn more →
▼ Double Top
Major reversal
2026-08-04 · $278.86
Two peaks ~$305.06 — bearish reversal confirmed
Learn more →
Momentum Signals 9
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
88%
7/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$339.36
+20.9% upside
Low $290
—
High $400
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
9.14%Last 12 Months
Operating Margin
3.98%Last 12 Months
Return on Equity
16.76%Last 12 Months
Revenue Growth
6.70%Year over Year
Free Cash Flow
7.98BLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
74.29Most Recent Quarter
Current Ratio
0.85Most Recent Quarter
Cash
7.26BMost Recent Quarter
Total Debt
31.88BMost Recent Quarter
Net Debt
—Most Recent Quarter
How CI Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 74.19B |
| Enterprise Value | 99.10B |
| Trailing P/E | 11.62 |
| Forward P/E | 8.38 |
| PEG Ratio (5yr) | 0.76 |
| Price/Sales (ttm) | 0.26 |
| Price/Book (mrq) | 1.74 |
| EV/Revenue | 0.35 |
| EV/EBITDA | 7.77 |
Share Statistics
| Avg Vol (3m) | 1.67M |
| Shares Outstanding | 264.24M |
| Float | 262.95M |
| % Held by Insiders | 1.44% |
| % Held by Institutions | 92.17% |
| Short Ratio | 3.55 |
| Short % of Float | 2.65% |
Profitability
| Gross Margin | 9.14% |
| Operating Margin (ttm) | 3.98% |
| Profit Margin | 2.27% |
| Return on Assets (ttm) | 4.46% |
| Return on Equity (ttm) | 16.76% |
Income Statement
| Revenue (ttm) | 282.38B |
| Revenue Growth (yoy) | 6.70% |
| Gross Profit (ttm) | 25.80B |
| EBITDA | 12.76B |
| Net Income (ttm) | 6.42B |
| Diluted EPS (ttm) | 24.17 |
| EPS Growth (yoy) | 10.20% |
Balance Sheet
| Total Cash (mrq) | 7.26B |
| Total Debt (mrq) | 31.88B |
| Debt / Equity (mrq) | 74.29 |
| Current Ratio (mrq) | 0.85 |
| Book Value / Share | 161.62 |
| Operating CF (ttm) | 10.28B |
| Free Cash Flow (ttm) | 7.98B |
Trading & Dividends
| Beta (5Y) | 0.32 |
| 50-Day MA | 283.41 |
| 200-Day MA | 279.68 |
| Fwd Dividend Yield | 2.22% |
| Payout Ratio | 25.39% |
Income
Dividend Yield
2.19%Last 12 Months
Annual Rate
6.24Forward
Payout Ratio
25.39%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 25.39%
Monthly Dividends
Ownership Breakdown
Institutional 92.17%
Insider 1.44%
Public 6.4%
Short Interest
2.65% of float
Low
Institutional 13F Holdings
Famous investors who disclosed a position in CI in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|